Nalaganje...
mir-101-3p is a key regulator of tumor metabolism in triple negative breast cancer targeting AMPK
mir-101-3p has been reported to be a tumor suppressor and a promising therapeutic target in cancer. Recently, AMPK dysfunction has been highlighted in cancers, including breast cancer. The aim of this study is to investigate the biological roles of mir-101-3p and AMPK in breast cancer. Our research...
Shranjeno v:
| izdano v: | Oncotarget |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Impact Journals LLC
2016
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5085220/ https://ncbi.nlm.nih.gov/pubmed/27145268 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.9072 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|